Mutations of the VHL tumour suppressor gene in renal carcinoma.
about
Wnt signaling pathways in urological cancers: past decades and still growingTracheal development and the von Hippel-Lindau tumor suppressor homolog in DrosophilaUbiquitination of a novel deubiquitinating enzyme requires direct binding to von Hippel-Lindau tumor suppressor proteinIdentification of novel VHL target genes and relationship to hypoxic response pathwaysExpression of the ammonia transporter, rh C glycoprotein, in normal and neoplastic human kidneyRegulation of receptor for activated C kinase 1 protein by the von Hippel-Lindau tumor suppressor in IGF-I-induced renal carcinoma cell invasivenessThe von Hippel-Lindau tumor suppressor stabilizes novel plant homeodomain protein Jade-1Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutationsUBE2QL1 is disrupted by a constitutional translocation associated with renal tumor predisposition and is a novel candidate renal tumor suppressor geneElongin (SIII): a multisubunit regulator of elongation by RNA polymerase IIRegulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2Transcription-dependent nuclear-cytoplasmic trafficking is required for the function of the von Hippel-Lindau tumor suppressor proteinSynthetic peptides define critical contacts between elongin C, elongin B, and the von Hippel-Lindau proteinMetabolism of kidney cancer: from the lab to clinical practicevon Hippel-Lindau disease: a clinical and scientific reviewState of the science: an update on renal cell carcinomaMethylation-specific PCR: a novel PCR assay for methylation status of CpG islandsIdentification of Ror2 as a hypoxia-inducible factor target in von Hippel-Lindau-associated renal cell carcinomaThe VHL tumor suppressor: master regulator of HIFDown-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenesNucleostemin mRNA is expressed in both normal and malignant renal tissuesIdentification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complexThe VHL protein recruits a novel KRAB-A domain protein to repress HIF-1alpha transcriptional activityCa2+-activated K+ channels in human melanoma cells are up-regulated by hypoxia involving hypoxia-inducible factor-1alpha and the von Hippel-Lindau proteinInhibition of HIF2alpha is sufficient to suppress pVHL-defective tumor growthPrevalence of von Hippel-Lindau gene mutations in sporadic renal cell carcinoma: results from The Netherlands cohort studyGene expression profiling predicts survival in conventional renal cell carcinoma.Hypoxic control of metastasisPrognostic Significance of Carbonic Anhydrase IX Expression in Cancer Patients: A Meta-Analysisc-Met as a Target for Personalized TherapyContribution of the Type II Chaperonin, TRiC/CCT, to OncogenesisExtraneural hemangioblastoma of the kidney: the challenge for clinicopathological diagnosisMolecular marker for predicting treatment response in advanced renal cell carcinoma: does the promise fulfill clinical need?Profile of tivozanib and its potential for the treatment of advanced renal cell carcinomaWhen ubiquitin meets NF-κB: a trove for anti-cancer drug developmentUnderstanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironmentMicroRNAs in the pathogenesis of cystic kidney diseaseRINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesisHypoxamiRs and cancer: from biology to targeted therapyTargeted therapies and the treatment of non-clear cell renal cell carcinoma
P2860
Q54604950-F15B3C33-C110-49B7-A141-1A0D044E3572Q54606041-228140A7-4C26-4482-8ADF-E774BBF1AC44Q54900630-F80190B2-5C4E-44DE-8EDD-348432A447DEQ54900633-D526D7F9-2C3A-4E37-9BA0-0ABB7F0AA73EQ54900639-83539983-98A1-4D66-9FEB-FC57046DB78AQ54900643-9F3879D6-B3D5-46D3-9E1E-A53863197333Q54900650-77EB5EA1-D68D-4D82-86AA-71520BA14D22Q54954564-72E8D45A-B6FF-40D0-BA95-D9527199E108Q54954595-1D08ABA7-F386-4DC7-A6E1-4D056A3E3F58Q54954614-94172BEE-003A-4800-9D42-52E6C3F34F34Q54954637-14A3F186-3AE5-4152-8C64-F915B3D563F3Q54954641-8CC53298-15C1-4B34-AA4C-EA7B01138D92Q54954642-306ECC94-4380-4D74-B11B-C14BDDC691F7Q54955686-8C6A2A30-7FA8-4DF3-A4DB-3CF3C4EA07A8Q54990782-0C2F8484-4CFF-443B-B5A8-A2F6375C490AQ54990783-2FB78C73-6C08-4BC0-8579-24DE49D0C316Q54990784-FFA77C91-6E1C-415E-8DD1-8FC2FE7CB4A2Q54990785-1E1075C1-EB2B-499A-865E-C95263255165Q54990787-F5FC8C21-4B79-48C6-B5F0-1933D9E179DBQ54990788-B2760D58-2318-457A-AF37-9BDA486BB34BQ54991268-1B6FB1DA-DC8C-404E-9449-0C357398EEFBQ54991269-4A2D23B4-7931-45B1-8402-3E5B6AB900A0Q54991282-9FBA7A6F-FF8E-440D-9A9A-40E8D17B1A27Q54991285-D1E97C2B-FA48-42C9-B86E-02F35DDD0BEBQ54991318-B7F068C0-ACDE-4A48-A602-8E9A71F40DE6Q54991322-B7263A3B-1FC5-48E6-80D5-9C52C800E248Q54991328-5176EBFA-BEC2-4338-96FE-7B11F2DFCA56Q54991342-6F4C47AC-4EFC-46F3-B2FE-3604819360A4Q54991357-769BE95E-EB7E-4C1D-9334-85ED4D44BFD6Q54991365-99FEE512-4142-4DAF-B853-C8CD82AC8A7AQ54991370-BB428E1A-C82B-4E39-8281-E8B409CC19DCQ54991371-B8332FD2-F08C-4F7A-B4BC-097F04D7A0AAQ54991373-366A3711-19BB-4E60-BFC6-40C5E985D909Q54991375-C785FD17-FCA8-410B-94E3-8BCC4FC3B938Q54991380-EF423897-8826-4F47-BE4D-DEC40B332799Q54991381-89296145-5CC6-4450-8751-A080A03A9E2CQ54991384-48E3ADC1-EAE9-4E17-8000-C7E37EE81A0FQ54991407-576E7420-E3D4-43B0-BB3F-3C3972154FC9Q54991408-05FD9D79-AE19-4F19-AE10-9D046C68ACB7Q54991409-7C7AA0A2-F105-435B-AED2-C23FE79C992E
P1343
Q21245761-3C8CF58E-3EA0-49E8-8470-95A897C5BA2AQ22254253-C497BC0D-423B-4478-B96B-77F0F2B6258BQ24291981-0263C7B0-4BBD-4C64-A1CF-162693F8A828Q24299968-D1F8EF62-FED5-4BBD-A89A-5A32860572FDQ24300575-23BC816E-D73D-40B5-98ED-17CCEB930AFAQ24301119-C6D8F1B7-59C0-4FCF-B2A2-439A55898818Q24304165-3905D014-DE20-43B4-A119-5000966C1663Q24317659-AB6E2B8E-F6BC-47CF-BE86-3C5A1B88182DQ24321830-336B96D7-8982-4DD5-838A-171D14E34227Q24336681-DBAFB58A-401B-44FC-91BC-AC5DC3C856E6Q24523680-CCDBFD39-46CB-49FD-B32F-4BBB7AD5967BQ24530637-669B1130-DD03-4A24-A591-9A054B7B3F69Q24563543-34918CEA-8510-40EB-91B5-AE2D15A7C5EBQ24600512-71FAD38E-B25E-42AB-93EB-DB8A78520232Q24622030-3B0AB67D-4900-413D-8B8D-BF91A420AC89Q24630685-D9629D9A-4CE6-4E06-AFC8-E456688A3956Q24631957-A89BC61E-3384-4423-A4AD-EC85BC55A81DQ24634004-6FDE8E22-A440-4431-9B7A-4871746894EDQ24634592-7AAA55B4-85D9-43A4-9822-34C5CFF46EF2Q24644903-3C017EFC-3078-402B-B95D-2C94EB30B4A1Q24651568-081B61B6-7CFC-4852-91F1-F1385EE442BCQ24654714-F73075EE-7D62-41E1-A9E3-6959298AD4AAQ24676311-4EE3DBC8-AA7F-4A41-A20D-C6D5EFB7ACC2Q24676422-D0FE9CEC-90D5-458A-AD81-CB3109437DF9Q24800550-98DAA962-5F51-41B3-A557-7F6F6B22B5E7Q24813050-C6921842-7FD0-47B7-88C2-A7EE679FD73DQ24814730-D234B114-EE5F-4AD1-8CBA-CF04ED7C300BQ26749159-87106E1E-E068-45AE-B196-C3DF2E714C2DQ26749393-96A7ABBD-27BA-472E-B506-F8D8E148DB46Q26775483-15563D4C-F908-4A72-9DE9-56D54F1E79B1Q26777412-C178EFFD-F362-4829-B5E8-13B72182DF68Q26800869-52F0DA99-44F8-4C35-8A55-0D3C9FCE0976Q26825512-E6C086CC-585C-4A0C-9A04-FFEB8987618DQ26827319-5ABE7A64-189A-47B5-9394-55DA1895EA5AQ26827754-0A3CC70B-96AF-4407-BABD-46F00F7D4738Q26852398-B55116DF-C4EB-4B49-B348-BA42DECC0275Q26852641-D180F55A-34A2-4FF8-8447-2FAE9D41B8ABQ26853207-1462B36E-CE1A-4ABE-8C33-5EFDE1407D8FQ26863298-A96E76A8-C212-4D94-A417-EEA017788FA7Q26995391-056B5494-87F2-4A8D-8F74-589D23B36D95
P2860
Mutations of the VHL tumour suppressor gene in renal carcinoma.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Mutations of the VHL tumour suppressor gene in renal carcinoma.
@en
Mutations of the VHL tumour suppressor gene in renal carcinoma.
@nl
type
label
Mutations of the VHL tumour suppressor gene in renal carcinoma.
@en
Mutations of the VHL tumour suppressor gene in renal carcinoma.
@nl
prefLabel
Mutations of the VHL tumour suppressor gene in renal carcinoma.
@en
Mutations of the VHL tumour suppressor gene in renal carcinoma.
@nl
P2093
P4510
P356
P1433
P1476
Mutations of the VHL tumour suppressor gene in renal carcinoma.
@en
P2093
P2888
P356
10.1038/NG0594-85
P407
P577
1994-05-01T00:00:00Z
P5875
P6179
1020232019